Stay updated on Intratumoral Daromun in Skin Cancer: Clinical Trial
Sign up to get notified when there's something new on the Intratumoral Daromun in Skin Cancer: Clinical Trial page.

Latest updates to the Intratumoral Daromun in Skin Cancer: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRecord History now includes updates for the last known status and recruitment status of NCT04362722, with Philogen S.p.A. listed as sponsor.SummaryDifference1%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice clarifying accessibility and response limitations.SummaryDifference13%

- Check45 days agoChange DetectedUpdated the revision from v3.0.2 to v3.1.0, indicating a new version but no evident changes to core content or pricing.SummaryDifference0.3%

- Check59 days agoChange DetectedThe page version is updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed as a minor UI change; no other substantive content changes were detected.SummaryDifference0.8%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.8%

- Check73 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference8%

Stay in the know with updates to Intratumoral Daromun in Skin Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral Daromun in Skin Cancer: Clinical Trial page.